Avantor, Inc. (NYSE:AVTR) Shares Acquired by Vestcor Inc

Vestcor Inc boosted its position in Avantor, Inc. (NYSE:AVTR) by 125.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 24,613 shares of the company’s stock after buying an additional 13,700 shares during the quarter. Vestcor Inc’s holdings in Avantor were worth $637,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cetera Advisors LLC acquired a new stake in shares of Avantor during the 1st quarter valued at approximately $249,000. SG Americas Securities LLC increased its stake in Avantor by 222.0% during the second quarter. SG Americas Securities LLC now owns 19,996 shares of the company’s stock valued at $424,000 after purchasing an additional 13,786 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Avantor by 2.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock valued at $571,000 after purchasing an additional 733 shares during the last quarter. ORG Partners LLC lifted its position in shares of Avantor by 5,773.0% in the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after buying an additional 5,773 shares during the last quarter. Finally, Swedbank AB boosted its holdings in shares of Avantor by 1.3% in the 2nd quarter. Swedbank AB now owns 107,182 shares of the company’s stock valued at $2,272,000 after buying an additional 1,327 shares during the period. 95.08% of the stock is owned by institutional investors.

Avantor Price Performance

Shares of NYSE:AVTR opened at $22.53 on Friday. The stock’s 50 day moving average price is $22.59 and its 200 day moving average price is $23.55. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The stock has a market cap of $15.33 billion, a price-to-earnings ratio of 48.98, a PEG ratio of 2.59 and a beta of 1.29. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Wells Fargo & Company cut their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Robert W. Baird cut their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. Barclays cut their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. Finally, UBS Group lowered their price target on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research report on Tuesday, October 8th. Three investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $27.69.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.